What You Should Know:
- MedEvolve, Inc., a pioneer in AI-powered revenue cycle automation and analytics, today announced its acquisition by Emergence, an enterprise backed by The Pritzker Organization. Financial details of the acquisition were not disclosed.
- The strategic transaction combines MedEvolve’s proprietary Effective Intelligence® platform—which integrates workflow automation, analytics, benchmarks, and generative AI—with Emergence’s long-term orientation and deep
Read More
RadNet Acquires CIMAR UK to Integrate Cloud-Native Imaging with DeepHealth AI
What You Should Know:
- RadNet, Inc., a provider of diagnostic imaging services and digital health solutions, announced the acquisition of CIMAR UK, a provider of cloud-native healthcare image management solutions. Financial details of the acquisition were not disclosed.
- CIMAR will be integrated into DeepHealth, RadNet’s wholly owned subsidiary and a global leader in AI-powered health informatics, to significantly advance connected imaging-based care.
CIMAR’s UK Market Dominance and
Read More
Evidium Raises $22M to Scale Computational Medical Knowledge
What You Should Know:
- Evidium, an innovative healthcare artificial intelligence company, has announced the close of its Series A equity funding round co-led by Health2047, the venture studio of the American Medical Association (AMA), and WGG Partners with additional participation from Interwoven Ventures and Mindset Ventures.
- The investment will be used to accelerate product development, expand the company's clinical modeling capabilities, and scale its go-to-market operations to
Read More
Cyber Resilience is Patient Safety: Why Healthcare Organizations Can’t Ignore Backup and Instant Recovery
Healthcare is under siege. Over the past five years, the sector has seen a 256% rise in cybersecurity breaches, as attackers grow more aggressive, more advanced and more relentless. Ransomware, phishing and supply chain attacks are evolving faster than most security teams can keep up with, and as a result, hospitals, clinics and care facilities are feeling the strain.
The reason? Healthcare is more connected than ever before. From bedside monitors and other internet of medical things (IoMT)
Read More
Hepta Emerges from Stealth with $6.7M to Pioneer AI-Driven Chronic Disease Liquid Biopsy
What You Should Know:
- Hepta, a biotechnology company focused on diagnosing chronic disease, has emerged from stealth announcing $6.7M in seed funding co-led by Felicis Ventures and Illumina Ventures, with participation from SeaX Ventures, Alumni Ventures, and AME Cloud Ventures.
- The company's core technology utilizes transformer-based AI to read the cell-free DNA (cfDNA) epigenome, enabling the detection of organ-specific signals for chronic conditions. Built by former leaders from
Read More
PocketHealth Launches Conductor Agentic AI System to Automate Every Non-Clinical Step of Care
What You Should Know:
- PocketHealth today announced the launch of Conductor, an agentic AI system built to automate every non-clinical step of care, from requisition intake and order creation to scheduling and appointment confirmations.
- The solution is directly aimed at helping healthcare systems across North America manage rising patient volumes, shrinking staff resources, and growing administrative costs.
I. Orchestrating Workflows to End the Administrative
Read More
AI Prior Authorization: Humata Health Partners with CMS on WISeR Model to Modernize Medicare
What You Should Know:
- Humata Health, a provider of AI-powered prior authorization technology, has been selected by the Centers for Medicare & Medicaid Services (CMS) as a key partner for its new initiative: the Wasteful and Inappropriate Service Reduction (WISeR) model.
- CMS, the single largest payer for healthcare in the U.S., has chosen Humata Health to deploy its proprietary technology in a program that directly addresses the staggering variability of care and significant
Read More
Onchilles Pharma Raises $25M to Advance N17350, Pioneering Next-Gen Cytotoxic Cancer Therapy
What You Should Know:
- Onchilles Pharma, a private biotech company pioneering next-generation cytotoxic therapeutics announced the publication of foundational preclinical data in the peer-reviewed journal Cell Reports Medicine, the close of a $25M Series A1 financing round.
- In addition, the company appointed Dr. Thomas A. Buchholz as a clinical advisor. The funding brings the total raised in Series A financing to $40M.
Foundational Preclinical Data Validates Cancer-Selective
Read More
Trump Unveils Historic Drug Price Cuts: Ozempic and Wegovy Reduced to $350 via TrumpRx
What You Should Know:
- President Donald J. Trump announced the latest in a series of significant actions to lower prescription drug prices, unveiling agreements with pharmaceutical manufacturers Eli Lilly and Company and Novo Nordisk.
- The initiative delivers historic price reductions on some of the world’s most popular drugs, impacting millions of Americans struggling with chronic diseases, diabetes, heart disease, and obesity.
Price Reductions for Patients and
Read More
Amae Health Secures $25M to Transform Severe Mental Illness Care with Integrated AI Platform
What You Should Know:
- Amae Health, a Public Benefit Corporation (PBC) and leader in outpatient treatment for Severe Mental Illness (SMI), announced the close of a $25M of pre-empted Series B financing led by Altos Ventures.
- The funding brings Amae’s total funding to more than $50M and will accelerate the company's mission to transform how conditions like schizophrenia, bipolar disorder, and treatment-resistant depression are understood and treated.
Achieving Significant and
Read More
